×
About 15,225 results

ALLMedicine™ Alzheimer Disease Center

Research & Reviews  5,345 results

Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease
https://clinicaltrials.gov/ct2/show/NCT05785156

Mar 27th, 2023 - A large series of recent studies have documented the frequency of the slowing of the action in brain diseases, especially vascular and neurodegenerative diseases. In stroke, the predictive value of action slowing at the acute phase for predicting ...

Plasma Concentrations of Calcium and Risk of Alzheimer Disease-Observational and Geneti...
https://doi.org/10.1093/clinchem/hvad030
Clinical Chemistry; Thomassen JQ, Nordestgaard BG et. al.

Mar 24th, 2023 - Dysregulation of calcium ion homeostasis in neurons is well documented in Alzheimer disease (AD), and high plasma calcium concentrations have been associated with cognitive decline in the elderly; however, a potential causal nature for this associ...

Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzhe...
https://doi.org/10.2967/jnumed.123.265667
Journal of Nuclear Medicine : Official Publication, Socie... Barthel H

Mar 24th, 2023 - Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease-What Lasts Long Finally Becomes Good?|2023|Barthel H,|

Sjogren Syndrome Differential Diagnoses
https://emedicine.medscape.com/article/332125-differential

Mar 24th, 2023 - Diagnostic Considerations Sjögren syndrome is associated with a wide variety of other disorders, which may contribute to underdiagnosis or misdiagnosis. A careful review of systems is needed to detect problems such as rheumatoid arthritis (RA), sy...

Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzhei...
https://doi.org/10.1097/RLU.0000000000004627
Clinical Nuclear Medicine; Ge J, Lin H et. al.

Mar 23rd, 2023 - This study aimed to optimize the analysis of cingulate island sign (CIS) to improve its diagnostic accuracy in discriminating dementia with Lewy bodies (DLB) from Alzheimer disease (AD). Patients with DLB (n = 80), AD (n = 75), and normal controls...

see more →

Guidelines  6 results

Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology
https://n.neurology.org/content/early/2023/03/08/WNL.0000000000207176
Neurology Agarwal P, Leurgans SE et. al.

Mar 8th, 2023 - Objective: Diet may reduce Alzheimer’s dementia risk and slow cognitive decline, but the understanding of the relevant neuropathologic mechanisms remains limited. The association of dietary patterns with Alzheimer’s disease (AD) pathology has been...

ACR Appropriateness Criteria® Dementia.
https://doi.org/10.1016/j.jacr.2020.01.040
Journal of the American College of Radiology : JACR; , Moonis G et. al.

May 7th, 2020 - Degenerative disease of the central nervous system is a growing public health concern. The primary role of neuroimaging in the workup of patients with probable or possible Alzheimer disease has typically been to exclude other significant intracran...

Falls Risk and Alzheimer Disease: A Patient Guide.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252520
Archives of Physical Medicine and Rehabilitation; Kahya M, Sood P et. al.

Mar 3rd, 2020 - Falls Risk and Alzheimer Disease: A Patient Guide.|2020|Kahya M,Sood P,Devos H,Krishnan S,Hirsch MA,|

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cogn...
https://doi.org/10.1016/j.jalz.2013.06.001
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Johnson KA, Minoshima S et. al.

Jul 3rd, 2013 - Amyloid PET imaging is a novel diagnostic test that can detect in living humans one of the two defining pathologic lesions of Alzheimer disease, amyloid-β deposition in the brain. The Amyloid Imaging Task Force of the Alzheimer's Association and S...

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326653
Genetics in Medicine : Official Journal of the American C... Goldman JS, Hahn SE et. al.

May 18th, 2011 - Alzheimer disease is the most common cause of dementia. It occurs worldwide and affects all ethnic groups. The incidence of Alzheimer disease is increasing due, in part, to increased life expectancy and the aging baby boomer generation. The averag...

see more →

Drugs  6 results see all →

Clinicaltrials.gov  246 results

Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease
https://clinicaltrials.gov/ct2/show/NCT05785156

Mar 27th, 2023 - A large series of recent studies have documented the frequency of the slowing of the action in brain diseases, especially vascular and neurodegenerative diseases. In stroke, the predictive value of action slowing at the acute phase for predicting ...

Self-screening of Cognitive Impairment in Primary Care
https://clinicaltrials.gov/ct2/show/NCT04019665

Mar 23rd, 2023 - According to 2011 HAS recommendations, early detection of Alzheimer disease is the major objective in order to allow an earlier care and support. These recommendations strengthen general practitioner role, who plays a key role in the identificatio...

Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care
https://clinicaltrials.gov/ct2/show/NCT01639586

Mar 22nd, 2023 - One of the interests of the Alzheimer Plan 2008-2010 is to provide increase support to helping families. It's also of major to involve the patient in the most active treatment possible, encouraging social inter relationship as well as cognitive an...

Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT02811653

Mar 22nd, 2023 - In AD (Alzheimer disease), the anatomic correlates of attention disorders (as evaluated by motor slowing) have not been thoroughly characterized.

Helicobacter Pylori Eradication Therapy for Epileptic Children
https://clinicaltrials.gov/ct2/show/NCT05297695

Mar 21st, 2023 - Helicobacter pylori (H. pylori) is a spiral-shaped Gram-negative bacterium, which causes chronic infection in more than 50% of human population. H. pylori infection is associated with several gastrointestinal disorders, such as gastritis and gastr...

see more →

News  486 results

Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology
https://n.neurology.org/content/early/2023/03/08/WNL.0000000000207176
Neurology Agarwal P, Leurgans SE et. al.

Mar 8th, 2023 - Objective: Diet may reduce Alzheimer’s dementia risk and slow cognitive decline, but the understanding of the relevant neuropathologic mechanisms remains limited. The association of dietary patterns with Alzheimer’s disease (AD) pathology has been...

Meaningful improvement for patients like Tante Ilse
https://www.mdedge.com/familymedicine/article/261627/mixed-topics/meaningful-improvement-patients-tante-ilse
MDedge Family Medicine; Henry C. Barry, MD, MS

Mar 7th, 2023 - Last year, after a long delay due to COVID, my father’s ashes were finally laid to rest at Arlington National Cemetery. Among the loved ones who came was my favorite aunt, Tante Ilse, who was suffering from dementia.

A Transdisciplinary Program for Care of Veterans With Neurocognitive Disorders
https://www.mdedge.com/fedprac/article/260120/neurology/transdisciplinary-program-care-veterans-neurocognitive-disorders
Mario F. Mendez, MD, PhD, Rebecca A. Melrose, PhD et. al.

Dec 14th, 2022 - Dementia is a devastating condition resulting in major functional, emotional, and financial impact on patients, their caregivers, and families. Approximately 6.

Defining Clinical Benefit in Oncology Trials Is Not as Simple as Some May Believe
https://www.onclive.com/view/defining-clinical-benefit-in-oncology-trials-is-not-as-simple-as-some-may-believe

Nov 14th, 2022 - A core component of any type of therapeutic research is to enhance clinical benefit.In appropriately designed, comparative, randomized studies another goal is to determine the superiority or potential equivalence of one therapeutic strategy vs ano...

Brain Aging in Black Adults Shows Accelerated Pattern Starting in Midlife
https://www.medpagetoday.com/neurology/dementia/101731

Nov 14th, 2022 - Black individuals showed an accelerated pattern of brain aging beginning in midlife, a cross-sectional analysis of two community-based cohorts showed. Brain aging -- the association of age with cortical thickness and white matter hyperintensity (W...

see more →

Patient Education  1 results see all →